DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20162869

A study to evaluate the in-vivo anticancer activity of ethanolic extract of Holoptelea integrifolia leaves against Ehrlich ascites carcinoma model using Swiss albino mice

Pramod S. G., Jayanthi M. K., Mruthunjaya K., Manjula S. N.

Abstract


Background: Herbs having ethnomedical uses is one of the best approaches in searching novel anticancer drugs. The aim of the present study is to evaluate the anticancer activity of ethanolic extract of Holoptelea integrifolia leaves against Ehrlich ascites carcinoma induced liquid tumor model using Swiss Albino mice.

Methods: Acute toxicity test was performed using Wistar albino rats before starting the in-vivo anticancer activity, were the MTD was more than 5000 mg/kg. Animals were divided into six groups of six animals each. 250mg/kg and 500 mg/kg of ethanolic extract of HI leaves, was administered orally for 9 days and Cisplatin (3.5 mg/kg, i.p., single dose). Various parameters like Change in body weight, Mean Survival Time, Percentage Increase in Life Span, Hematological & Biochemical parameters were assessed.

Results: All the parameters were considerably restored towards the normal values. HIAL500mg/kg showed more significant results than 250 mg/kg. Hence 500mg/kg was taken for combination study with standard drug Cisplatin.

Conclusions: On the basis of the above result it was suggested that, the in-vivo anticancer activity of ethanolic extract of Holoptelea integrifolia leaves possess significant anticancer property with the dose dependent effect. This may probably due to the presence of phytochemicals such as alkaloids, phenols and flavonoids.


Keywords


Holoptelea integrifolia, Cisplatin, Ethanolic extract, Ehrlich Ascites Carcinoma, Swiss albino mice

Full Text:

PDF

References


Freemantle SJ, Liu X, Feng Q, Galimberti F, Blumen S, Sekula D, Kitareewan S, Dragnev KH, Dmitrovsky EJ. Cyclin degradation for cancer therapy and chemoprevention. Cell Biochem. 2007;102(4):869-77.

Available at: http://www.who.int/mediacentre/factsheets/fs297/en/index.html-accessed 20/8/ 2011.

Pratt WB, Ruddon RW, Ensminger WD and Maybaum J. The Anticancer Drugs. Oxford University Press; USA, 1994.

Jayaseelan RS, Vijayan PF, Mathesvaran MS, Padikkala J. Cytotoxic and antitumor activity of methanolic extract desmodium triangulare. Root. International Journal of Pharmacy and Pharmaceutical Sciences; 2012;4(3):0975-1491.

Sharma J, Singh V. Holoptelea integrifolia: an overview. European Journal of Applied Sciences. 2012;4(1):42-6.

Jagetia GC, Venkatesha VAK. Enhancement of radiation effect by Aphanamixis polystachya in mice transplanted with Ehrlich ascites carcinoma. Biol Pharma Bull. 2005;28(1):69-77.

HiMedia Laboratories. Available at: http://himedialabs.com accessed 13/1/14.

Swemed Biomedicals Pvt. Ltd. Available at: http:// www.swemedbio.com/ pdf/ SGOT_KIT.pd. Accessed 25/1/14.

Dasgupta T, Rao AR, Yadava PK. Modulatory effect of Henna leaf (Lawsonia inermis ) on drug metabolizing phase I and phase II enzymes, antioxidant enzymes, lipid peroxidation and chemically induced skin and forestomach papillomagenesis in mice. Molecular and cellular biochemistry. 2003;245:11-22.

Pariani S, Buscaglia M, Piantanida M, Simoni G. Cyclophosphamide increases the frequency of sister chromatid exchange in direct preparations of human chorionic villi in the absence of supplementary enzymatic activation system. I Med Genet. 1992;29:109-11.

Kim J, Park E. Chem Antican Agent. J Curr Med. 2002;2:485-537.

Gupta M, Mazumder UK, Sambath kumar R, Sivakumar T, Vamsi MLM. Antitumor activity and antioxidant status of Caesalpinia bonducella against ehrlich ascites carcinoma in swiss albino mice. J Pharmacol Sci. 2004;94:177-84.

Price VE, Greenfield RE. Anemia in cancer. Adv Cancer Res. 1958;2:229-53.

El-Beshbishy HA. The effect of dimethyl dimethoxy biphenyl dicarboxylase against tamoxifen-induced liver injury in rats. DDB use is curative or protective. J biochem Mol Biol. 2005;8:300-6.